PERIZOL 1GT (Peritoneal Dialysis Solution With 1.5% Dextrose)

Pajjiż: Malasja

Lingwa: Ingliż

Sors: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ingredjent attiv:

Calcium chloride; Magnesium Chloride; Sodium Lactate USP; Sodium Chloride BP; Dextrose Anhydrous BP

Disponibbli minn:

AIN MEDICARE SDN. BHD.

INN (Isem Internazzjonali):

Calcium chloride; Magnesium Chloride; Sodium Lactate USP; Sodium Chloride BP; Dextrose Anhydrous BP

Unitajiet fil-pakkett:

5000ml mL

Manifatturat minn:

AIN MEDICARE SDN. BHD.

Karatteristiċi tal-prodott

USER INFORMATION
READ CAREFULLY
PERIZOL
1GT
Continuous Ambulatory Peritoneal Dialysis (CAPD) Solution with 1.5%
Dextrose
______________________________________________________________________
Continuous Ambulatory Peritoneal Dialysis Solution, sterile and
non-pyrogenic
Composition:
Sodium Chloride BP
5.38 g
Calcium Chloride BP
0.183 g
Magnesium Chloride BP
0.0508 g
Sodium Lactate USP
4.48 g
Dextrose Anhydrous BP
15.00 g
Water For Injection BP to 1000 mL
Electrolytes:
The electrolytes of PERIZOL 1GT:
Electrolytes
mmol/L mEq/L
Sodium Ion (Na
+
)
132.00 132.00
Calcium Ion (Ca
++
)
1.25
2.50
Magnesium Ion (Mg
++
)
0.25
0.50
Chloride Ion (Cl
-
)
95.00
95.00
Bicarbonate Ion (as Lactate)
40.00
40.00
Indications:
Acute renal failure. (e.g. before transfer to Dialysis Centre).
Chronic renal failure. (e.g. temporary dialysis, intermittent
to long term dialysis before diagnostic or surgical procedures).
Acute intoxication. (e.g. of barbiturates, salicylates, methanol).
Refractory Odema after therapy. (e.g. cardiac insufficiency).
Adverse Reactions:
Loss of protein into dialysate.
Usage:
Intraperitoneal Dialysis fluid.
Contraindications:
Abdominal adhesion.
Immediately after abdominal surgery, specifically transection of the
retroperitoneum.
Pregnancy.
Hypercalcaemia.
Hyperlactataemia.
Dosage:
Administer in portions of 1-2 litres into the abdominally cavity.
Solution to be retained
about 10-15 minutes and then to be drained out.
Normally 60-80 litres of dialysate are needed per treatment unless
advised otherwise
attending physician.
Precautions/Warnings:
Discard any portion not used when the seal is first broken. Before use
check for
minute leaks by squeezing bag firmly. Discard if leakage is detected.
If any
solid particles, growth or turbidity appears during storage, the
product should
not be used.
The administration of PERIZOL 1GT has to be strictly carried out under
aseptic condition
s
Expiry:
3 years from date of manufacture. Do not use after expiry.
_ _
Storage condition:
Do not store above 30
0
C
Presentation:
5000mL